Lv41
780 积分 2020-11-10 加入
A cryptic pocket in CB1 drives peripheral and functional selectivity
4天前
已完结
Ketamine: A Paradigm Shift for Depression Research and Treatment
5天前
已完结
Tetrazoles: A multi-potent motif in drug design
5天前
已完结
Ro 25–6981, a Highly Potent and Selective Blocker of N-Methyl-d-aspartate Receptors Containing the NR2B Subunit. Characterization in Vitro
7天前
已完结
Discovery of novel tryptamine derivatives as GluN2B subunit-containing NMDA receptor antagonists via pharmacophore-merging strategy with orally available therapeutic effect of cerebral ischemia
7天前
已完结
GluN2A mediates ketamine-induced rapid antidepressant-like responses
8天前
已完结
Preclinical pharmacological characterisation of the selective NR2B negative allosteric modulator BI 1569912 with potential to treat major depressive disorder
8天前
已完结
P376. Preclinical Pharmacological Characterization of the Selective NR2b Negative Allosteric Modulator BI 1569912 With Potential to Treat MDD
8天前
已完结
P712. Safety, Tolerability, and Pharmacokinetics of Single Rising Doses of Bi 1569912 in Healthy Males: A Phase I Study
8天前
已完结
P285. Pharmacological Effects of the Novel NR2B Modulator Bi 1569912 on Electroencephalography and Eye-Tracking in a Phase I Study
8天前
已完结
皖公网安备34019202002308
